Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Assets Average (2016 - 2025)

Historic Assets Average for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q3 2025 value amounting to $1.4 billion.

  • Agios Pharmaceuticals' Assets Average rose 1138.8% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 1138.8%. This contributed to the annual value of $1.3 billion for FY2024, which is 1950.89% up from last year.
  • Per Agios Pharmaceuticals' latest filing, its Assets Average stood at $1.4 billion for Q3 2025, which was up 1138.8% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Agios Pharmaceuticals' Assets Average ranged from a high of $2.2 billion in Q2 2021 and a low of $811.4 million during Q2 2024
  • Its 5-year average for Assets Average is $1.4 billion, with a median of $1.3 billion in 2022.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Assets Average surged by 14568.32% in 2021, and later plummeted by 4067.6% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Assets Average (Quarter) stood at $1.5 billion in 2021, then fell by 18.8% to $1.2 billion in 2022, then decreased by 19.62% to $972.2 million in 2023, then surged by 77.69% to $1.7 billion in 2024, then dropped by 17.31% to $1.4 billion in 2025.
  • Its Assets Average was $1.4 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.6 billion in Q1 2025.